139 related articles for article (PubMed ID: 17108210)
1. Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.
Frattini M; Gallino G; Signoroni S; Balestra D; Battaglia L; Sozzi G; Leo E; Pilotti S; Pierotti MA
Ann N Y Acad Sci; 2006 Sep; 1075():185-90. PubMed ID: 17108210
[TBL] [Abstract][Full Text] [Related]
2. Free circulating DNA as possible tumour marker in colorectal cancer.
Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
[TBL] [Abstract][Full Text] [Related]
3. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer.
Frattini M; Gallino G; Signoroni S; Balestra D; Lusa L; Battaglia L; Sozzi G; Bertario L; Leo E; Pilotti S; Pierotti MA
Cancer Lett; 2008 May; 263(2):170-81. PubMed ID: 18395974
[TBL] [Abstract][Full Text] [Related]
4. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
Thijssen MA; Swinkels DW; Ruers TJ; de Kok JB
Anticancer Res; 2002; 22(1A):421-5. PubMed ID: 12017326
[TBL] [Abstract][Full Text] [Related]
5. Persistence of K-ras mutations in plasma after colorectal tumor resection.
Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
7. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
10. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
[TBL] [Abstract][Full Text] [Related]
11. Circulating free tumor DNA and colorectal cancer.
Lecomte T; Ceze N; Dorval E; Laurent-Puig P
Gastroenterol Clin Biol; 2010 Dec; 34(12):662-81. PubMed ID: 20832215
[TBL] [Abstract][Full Text] [Related]
12. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.
Huang ZH; Li LH; Hua D
Cancer Lett; 2006 Nov; 243(1):64-70. PubMed ID: 16412565
[TBL] [Abstract][Full Text] [Related]
14. Quantification of circulating DNA in the plasma and serum of cancer patients.
Taback B; O'Day SJ; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():17-24. PubMed ID: 15251934
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients.
Taback B; Saha S; Hoon DS
Ann N Y Acad Sci; 2006 Sep; 1075():197-203. PubMed ID: 17108212
[TBL] [Abstract][Full Text] [Related]
16. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
[TBL] [Abstract][Full Text] [Related]
17. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells.
García-Olmo DC; Domínguez C; García-Arranz M; Anker P; Stroun M; García-Verdugo JM; García-Olmo D
Cancer Res; 2010 Jan; 70(2):560-7. PubMed ID: 20068178
[TBL] [Abstract][Full Text] [Related]
18. Circulating DNA in plasma or serum.
Anker P; Stroun M
Medicina (B Aires); 2000; 60(5 Pt 2):699-702. PubMed ID: 11188885
[TBL] [Abstract][Full Text] [Related]
19. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract][Full Text] [Related]
20. Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy.
Cheng C; Omura-Minamisawa M; Kang Y; Hara T; Koike I; Inoue T
Cancer Sci; 2009 Feb; 100(2):303-9. PubMed ID: 19200259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]